Expiring federal contract
75N93023P00594 — Dna Twopointo INC.
Department of Health and Human Services · National Institutes of Health
- Contract / PIID
- 75N93023P00594
- Incumbent
- Dna Twopointo INC.
- Incumbent UEI
- G9S3SC8T5DM1
- Current end date
- May 13, 2027
- Potential total value
- $300,000
- Obligated
- $300,000
- NAICS
- 325414 — Biological Product (except Diagnostic) Manufacturing
- PSC
- 6505 — DRUGS AND BIOLOGICALS
- Set-aside
- Full & Open
- Start date
- May 14, 2023
- Place of performance
- CA
- Award type
- PURCHASE ORDER
Source: USASpending.gov award record, last checked November 18, 2026. Place of performance as reported by USASpending.
What the contract covers
YEARLY LICENSE (MAINTENANCE FEE AND IND FILING FEE) TO USE A MONOCLONAL ANTIBODY PRODUCED VIA ATUM PROPRIETARY CELL LINE TECHNOLOGY
Likely rebid window (estimate)
- Sources Sought / RFI: about May 2026 – Nov 2026 (6–12 months before the end date)
- RFP: about Jan 2027 – Mar 2027 (2–4 months before the end date)
Between the estimated Sources Sought and RFP windows.
Estimated from the current end date using typical federal recompete timing. Agencies set their own schedules, and contracts are often extended. This is not a published solicitation date.
Track this recompete free
- Change history: no changes recorded since Mindy began tracking this contract.
- Alerts: get an email when the end date moves or the follow-on is posted.
- Contacts: the buying office and small-business contacts for this agency.
Other contracts expiring at Department of Health and Human Services (NAICS 325414)
- 75A50125C00002 — Sanofi Vaccines US INC. · ends January 31, 2027 · $53M
- 75A50124F61004 — Advanced Technology International · ends April 11, 2027 · $51M
- 75A50126F61013 — Seqirus INC · ends May 8, 2027 · $450K
- 75N98026P00545 — Somalogic Operating CO., INC · ends May 14, 2027 · $522K
- 75A50124F61008 — Seqirus INC · ends May 21, 2027 · $23M
- 75A50124F61009 — Seqirus INC · ends May 21, 2027 · $396K
- 75N98026P00626 — Olink Proteomics INC · ends May 28, 2027 · $207K
- 75N98026P00928 — Pacific Biosciences Of California, INC · ends July 7, 2027 · $347K
- 75N98026P01001 — Life Technologies Corporation · ends August 6, 2027 · $110K
- 75N98026F00001 — Roche Diagnostics Corporation · ends August 31, 2027 · $127K